SWP
GNOM icon

Stratos Wealth Partners’s Global X Genomics & Biotechnology ETF GNOM Stock Holding History

Stratos Wealth Partners’s Portfolio GNOM Stock Details GNOM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$639K Sell
14,615
-125
-0.8% -$5.78K 0.01% 968
2025
Q4 		$670K Buy
14,740
+158
+1% +$7K 0.01% 921
2025
Q3 		$566K Buy
14,582
+193
+1% +$6.99K 0.01% 964
2025
Q2 		$485K Sell
14,389
-1,157
-7% -$36.6K 0.01% 943
2025
Q1 		$494K Buy
15,546
+150
+1% +$5.69K 0.01% 889
2024
Q4 		$598K Sell
15,396
-2,520
-14% -$106K 0.01% 862
2024
Q3 		$806K Sell
17,916
-2,294
-11% -$103K 0.01% 761
2024
Q2 		$844K Buy
20,210
+1,857
+10% +$77.6K 0.01% 710
2024
Q1 		$835K Buy
18,353
+7,099
+63% +$323K 0.01% 708
2023
Q4 		$520K Buy
11,254
+1,504
+15% +$61.3K 0.01% 866
2023
Q3 		$397K Buy
9,750
+831
+9% +$37.8K 0.01% 908
2023
Q2 		$432K Buy
8,919
+1,802
+25% +$90.1K 0.01% 822
2023
Q1 		$351K Buy
7,117
+808
+13% +$41.6K 0.01% 814
2022
Q4 		$319K Buy
6,309
+75
+1% +$3.87K 0.01% 869
2022
Q3 		$313K Buy
6,234
+716
+13% +$40.4K 0.01% 843
2022
Q2 		$270K Buy
5,518
+1,962
+55% +$99.5K 0.01% 971
2022
Q1 		$214K Buy
+3,556
New +$224K ﹤0.01% 1137

Other funds holding GNOM

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
OAM
Oppenheimer Asset Management New York $8.76B AUM 23.12% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
USCWA
U.S. Capital Wealth Advisors Austin, Texas $3.98B AUM 22.36% 1-Year Est. Return
AA
Armis Advisers Atlanta, Georgia $1.09B AUM 22.88% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
CFD
Creative Financial Designs Kokomo, Indiana $1.65B AUM 15.6% 1-Year Est. Return
SWA
Sightline Wealth Advisors Groton, Connecticut $236M AUM 12.89% 1-Year Est. Return

Stratos Wealth Partners's GNOM Position: Q1 2026 in Review

Stratos Wealth Partners reduced its Global X Genomics & Biotechnology ETF (GNOM) stake by 0.85% in Q1 2026, selling an estimated $5.78K and leaving 14,615 shares worth $639K. The position accounts for 0.01% of the portfolio, ranked #968.

Stratos Wealth Partners first reported a position in GNOM in Q1 2022 and has held it in 17 quarters since. The position peaked at $844K in Q2 2024. 40 funds tracked by Wall St. Rank hold GNOM as of Q1 2026.

  • Stratos Wealth Partners held 14,615 shares of Global X Genomics & Biotechnology ETF worth $639K as of Q1 2026.
  • Stratos Wealth Partners sold 125 Global X Genomics & Biotechnology ETF shares in Q1 2026, an estimated $5.78K.
  • Global X Genomics & Biotechnology ETF made up 0.01% of Stratos Wealth Partners's portfolio in Q1 2026, its #968 holding.
  • Stratos Wealth Partners first reported a position in Global X Genomics & Biotechnology ETF in Q1 2022 and has held it in 17 quarters since.
  • Stratos Wealth Partners's Global X Genomics & Biotechnology ETF position peaked at $844K in Q2 2024.
  • 40 funds tracked by Wall St. Rank held Global X Genomics & Biotechnology ETF as of Q1 2026.

Based on Stratos Wealth Partners's 13F filing for Q1 2026, filed 28 Apr 2026.